UNLABELLED: The aim of this study was to evaluate the clinical, therapeutic, laboratory, and radiological differences between respiratory syncytial virus (RSV) and non-RSV bronchiolitis in order to assess if the prior knowledge of viral etiology changed management decisions and would be able to predict outcomes. Medical charts of children <1 year admitted to the emergency department with bronchiolitis during two RSV seasons (2010-2012) were reviewed. We analyzed 221 episodes of bronchiolitis. The percentage of exams performed (95 % confidence interval (CI) 0.74-2.52), abnormal laboratory and radiological findings (95 % CI 0.53-16.89) did not differ between groups. RSV bronchiolitis had a more severe clinical course. However, virologic testing for RSV had low specificity in identifying at-risk patients for hospitalization, longer hospital length of stay, and need of oxygen therapy and nasogastric tube (44, 40, 42, and 35 %, respectively), and while statistically significant, the positive likelihood ratios were only slightly greater than 1. CONCLUSION: Although RSV bronchiolitis has a more severe clinical course, virologic testing does not help in management decisions, and at an individual level, as a performance test, it seems insufficient to precisely predict outcomes.
UNLABELLED: The aim of this study was to evaluate the clinical, therapeutic, laboratory, and radiological differences between respiratory syncytial virus (RSV) and non-RSV bronchiolitis in order to assess if the prior knowledge of viral etiology changed management decisions and would be able to predict outcomes. Medical charts of children <1 year admitted to the emergency department with bronchiolitis during two RSV seasons (2010-2012) were reviewed. We analyzed 221 episodes of bronchiolitis. The percentage of exams performed (95 % confidence interval (CI) 0.74-2.52), abnormal laboratory and radiological findings (95 % CI 0.53-16.89) did not differ between groups. RSV bronchiolitis had a more severe clinical course. However, virologic testing for RSV had low specificity in identifying at-risk patients for hospitalization, longer hospital length of stay, and need of oxygen therapy and nasogastric tube (44, 40, 42, and 35 %, respectively), and while statistically significant, the positive likelihood ratios were only slightly greater than 1. CONCLUSION: Although RSV bronchiolitis has a more severe clinical course, virologic testing does not help in management decisions, and at an individual level, as a performance test, it seems insufficient to precisely predict outcomes.
Authors: E Bamberger; I Srugo; B Abu Raya; E Segal; B Chaim; I Kassis; A Kugelman; D Miron Journal: Eur J Clin Microbiol Infect Dis Date: 2012-07-24 Impact factor: 3.267
Authors: Jonathan M Mansbach; Sunday Clark; Norman C Christopher; Frank LoVecchio; Sarah Kunz; Uchechi Acholonu; Carlos A Camargo Journal: Pediatrics Date: 2008-04 Impact factor: 7.124
Authors: Dorothy Damore; Jonathan M Mansbach; Sunday Clark; Maria Ramundo; Carlos A Camargo Journal: Acad Emerg Med Date: 2008-09-15 Impact factor: 3.451
Authors: Christophe Marguet; Marc Lubrano; Marie Gueudin; Pascal Le Roux; Antoine Deschildre; Chantal Forget; Laure Couderc; Daniel Siret; Marie-Dominique Donnou; Michael Bubenheim; Astrid Vabret; François Freymuth Journal: PLoS One Date: 2009-02-25 Impact factor: 3.240
Authors: Daniel A Green; Letiana Hitoaliaj; Brian Kotansky; Sheldon M Campbell; David R Peaper Journal: J Clin Microbiol Date: 2016-09-21 Impact factor: 5.948
Authors: Mayanka Tickoo; Robin Ruthazer; Amit Bardia; Shira Doron; Gabriela M Andujar-Vazquez; Bradley J Gardiner; David R Snydman; Sebastian G Kurz Journal: BMC Pulm Med Date: 2019-07-01 Impact factor: 3.317
Authors: Shana A B Burrowes; Alec Rader; Pengsheng Ni; Mari-Lynn Drainoni; Tamar F Barlam Journal: Open Forum Infect Dis Date: 2020-03-03 Impact factor: 3.835